GO:0008988 rRNA (adenine-N6-)-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008988 describes the enzymatic transfer of a methyl group from S-adenosyl-L-methionine to the N6 position of adenine in ribosomal RNA, producing N6-methyladenosine and S-adenosyl-L-homocysteine [1, 7].
• The best-characterized enzyme carrying this activity is KsgA (also called Dim1 in eukaryotes and archaea), which dimethylates two adjacent adenines near the 3' end of 16S rRNA to form m6(2)A [5, 7].
• KsgA/Dim1-dependent rRNA methylation is conserved from bacteria to humans and is essential for proper ribosome assembly and translation fidelity [5, 6].
• Loss of KsgA activity leads to increased sensitivity to aminoglycoside antibiotics such as kasugamycin and to oxidative stress in Pseudomonas aeruginosa.
• In addition to its rRNA methyltransferase function, KsgA from Escherichia coli possesses a DNA glycosylase/AP lyase activity that helps prevent mutations.
• Studying GO:0008988 requires combining structural biology, methyltransferase assays, and CRISPR-based knockout or point-mutation models to dissect its role in ribosome biogenesis and disease [2, 4, 6].
Description
GO:0008988, rRNA (adenine-N6-)-methyltransferase activity, is a molecular function that catalyzes the methylation of adenine residues at the N6 position within ribosomal RNA using S-adenosyl-L-methionine as the methyl donor [1, 7]. This modification, typically forming N6-methyladenosine or dimethyladenosine, is one of the most conserved rRNA modifications across all domains of life and is critical for ribosome assembly and function [5, 7]. The enzyme responsible, known as KsgA in bacteria and Dim1 in eukaryotes and archaea, introduces these methyl groups at specific adenines near the 3' terminus of the small subunit rRNA [5, 7]. Researchers study this activity because it directly impacts translation fidelity, antibiotic resistance, and cellular stress responses [3, 6]. In Pseudomonas aeruginosa, loss of KsgA increases susceptibility to oxidative stress and certain antibiotics, highlighting its clinical relevance. In eukaryotes, the mitochondrial and cytosolic homologs are essential for organellar and cytosolic translation, linking this activity to human disease when mutated. Understanding GO:0008988 therefore provides insight into fundamental ribosome biology and potential therapeutic targets.
rRNA (adenine-N6-)-methyltransferase activity At A Glance
| GO ID | GO:0008988 |
|---|---|
| GO term | rRNA (adenine-N6-)-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | ErmC 23S rRNA methyltransferase; gene ksgA methyltransferase; ribonucleic acid-adenine (N6) methylase activity; S-adenosyl-L-methionine:rRNA (adenine-N6-)-methyltransferase activity |
| Major function | Methylation of adenine at the N6 position in rRNA using S-adenosyl-L-methionine as methyl donor |
| Reaction | adenosine in rRNA + S-adenosyl-L-methionine = H+ + N(6)-methyladenosine in rRNA + S-adenosyl-L-homocysteine |
| Representative enzymes | KsgA (bacteria), Dim1 (eukaryotes/archaea), mitochondrial rRNA dimethyladenosine methyltransferase |
| Conservation | Conserved from bacteria to humans; essential for ribosome biogenesis and translation |
What Is GO:0008988?
In simple terms, this GO term describes an enzyme that attaches a methyl group to a specific nitrogen atom (N6) of adenine within ribosomal RNA. The reaction consumes S-adenosyl-L-methionine and produces S-adenosyl-L-homocysteine plus the methylated rRNA. This activity is responsible for generating N6-methyladenosine in rRNA, a modification that influences ribosome structure and function [1, 7].
Why Is rRNA (adenine-N6-)-methyltransferase activity Important in Cell Biology?
GO:0008988 is important because the methylation it catalyzes is a conserved and essential step in ribosome assembly, directly affecting translation accuracy and cellular responses to stress and antibiotics [3, 5, 7]. Disruption of this activity leads to ribosome maturation defects, increased sensitivity to aminoglycosides, and in higher organisms, mitochondrial dysfunction [3, 4]. Moreover, the KsgA enzyme has additional DNA repair functions, linking rRNA methylation to genome stability.
• Essential for 16S rRNA maturation and 30S ribosomal subunit assembly [5, 7].
• Influences translation fidelity and stop codon readthrough.
• Confers resistance to aminoglycoside antibiotics like kasugamycin in bacteria.
• Protects against oxidative stress in Pseudomonas aeruginosa.
• Mitochondrial homologs are required for organellar translation and cellular respiration.
• Mutations in Dim1 homologs are linked to ribosomopathies and developmental disorders.
• KsgA has a secondary DNA glycosylase/AP lyase activity that prevents mutations.
• Target for antibacterial drug development due to its essential role in bacteria [2, 3].
• Plasmodium falciparum rRNA methyltransferase is a potential antimalarial target.
• Archaeal KsgA/Dim1 provides insights into evolution of rRNA modification.
Mechanism, Genes and Research Methods
Substrate Recognition and Binding
In simple terms: The enzyme first grabs the rRNA and the methyl donor molecule.
KsgA/Dim1 specifically recognizes a hairpin loop near the 3' end of 16S rRNA, including the conserved adenines A1518 and A1519 (E. coli numbering) [5, 7]. Structural studies show that the enzyme uses its N-terminal domain to bind the rRNA and its C-terminal catalytic domain to bind S-adenosyl-L-methionine. Two dynamic N-terminal regions are required for function in ribosomal RNA adenine dimethylase family members.
Catalytic Methyl Transfer
In simple terms: The enzyme transfers two methyl groups onto the adenine ring.
The reaction proceeds via a sequential mechanism where S-adenosyl-L-methionine donates a methyl group to the N6 position of the target adenine, forming N6-methyladenosine, and then a second methylation yields N6,N6-dimethyladenosine (m6(2)A). This successive modification is facilitated by a conserved catalytic triad and a flexible loop that repositions the substrate between methylations.
Ribosome Assembly and Quality Control
In simple terms: The methylation acts like a stamp of approval for the ribosome to assemble correctly.
The m6(2)A modification is introduced early during 30S subunit assembly and serves as a checkpoint for correct folding of the 16S rRNA. In its absence, ribosomal subunits are misassembled, leading to reduced translation and increased sensitivity to antibiotics [3, 5].
Additional DNA Repair Activity
In simple terms: Some versions of the enzyme can also fix damaged DNA.
Escherichia coli KsgA possesses a DNA glycosylase/AP lyase activity that removes oxidized bases from DNA, preventing mutations. This dual function suggests a broader role in genome maintenance beyond rRNA methylation.
Key Genes Involved in GO:0008988 rRNA (adenine-N6-)-methyltransferase activity
The following genes and proteins are directly associated with rRNA (adenine-N6-)-methyltransferase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ksgA (E. coli) | 16S rRNA adenine dimethyltransferase; also DNA glycosylase | Model for dual-function enzymes; antibiotic resistance studies [1, 3] |
| DIM1 (S. cerevisiae) | Mitochondrial and cytosolic 18S rRNA dimethylase | Ribosome assembly and mitochondrial function |
| DIM1 (human) | Mitochondrial 12S rRNA dimethylase | Ribosomopathies and mitochondrial disease |
| KsgA (P. aeruginosa) | 16S rRNA methyltransferase | Oxidative stress and antibiotic resistance |
| PfKsgA (P. falciparum) | Apicoplast rRNA methyltransferase | Antimalarial drug target |
| KsgA/Dim1 (archaea) | rRNA modification in archaea | Evolution of rRNA methylation |
| ErmC | 23S rRNA methyltransferase (erythromycin resistance) | Antibiotic resistance mechanisms |
| RsmA | 16S rRNA methyltransferase (m6(2)A) | Ribosome assembly and translation |
| RsmB | 16S rRNA methyltransferase (m5C) | Ribosome maturation |
| RsmC | 16S rRNA methyltransferase (m2G) | Ribosome function |
| RsmD | 16S rRNA methyltransferase (m2G) | Ribosome assembly |
| RsmE | 16S rRNA methyltransferase (m3U) | Ribosome maturation |
| RsmF | 16S rRNA methyltransferase (m5C) | Ribosome function |
| RsmG | 16S rRNA methyltransferase (m7G) | Streptomycin resistance |
| RsmH | 16S rRNA methyltransferase (m4C) | Ribosome assembly |
| RsmI | 16S rRNA methyltransferase (m2C) | Ribosome function |
| RlmA | 23S rRNA methyltransferase (m1G) | Antibiotic resistance |
| RlmB | 23S rRNA methyltransferase (m2G) | Ribosome assembly |
How Is rRNA (adenine-N6-)-methyltransferase activity Regulated?
The expression and activity of KsgA/Dim1 are regulated at multiple levels. In bacteria, ksgA is under the control of growth rate-dependent promoters and is induced during stationary phase. In eukaryotes, Dim1 is regulated by the target of rapamycin (TOR) pathway, which couples ribosome biogenesis to nutrient availability. Additionally, the enzyme's activity can be modulated by post-translational modifications, such as phosphorylation, although specific sites remain to be fully characterized.
rRNA (adenine-N6-)-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DIM1 (human) | Mitochondrial disease, ribosomopathy | Knockout in HEK293T cells; patient-derived fibroblasts |
| ksgA (P. aeruginosa) | Antibiotic resistance, oxidative stress | Knockout in PAO1; mouse infection model |
| PfKsgA | Malaria | Knockout in P. falciparum; antimalarial screening |
| ksgA (E. coli) | Mutagenesis, DNA repair | Knockout in MG1655; mutation accumulation assays |
| DIM1 (S. cerevisiae) | Mitochondrial function | Knockout in BY4741; growth on non-fermentable carbon |
Ribosomopathies and Mitochondrial Disease
Mutations in the human mitochondrial rRNA methyltransferase (a Dim1 homolog) cause defective mitochondrial translation, leading to oxidative phosphorylation deficiencies and clinical presentations such as encephalopathy, cardiomyopathy, and lactic acidosis. These conditions fall under the umbrella of ribosomopathies, where impaired ribosome assembly triggers p53-mediated apoptosis in affected tissues.
Antibiotic Resistance and Infectious Disease
In pathogenic bacteria like Pseudomonas aeruginosa, loss of KsgA increases susceptibility to aminoglycosides and oxidative stress, whereas its overexpression confers resistance. In Plasmodium falciparum, the apicoplast rRNA methyltransferase is essential for parasite survival and is being explored as a drug target.
Cancer and Genome Stability
The DNA glycosylase activity of KsgA in E. coli prevents mutations, suggesting that loss of this dual function could contribute to genomic instability. In human cells, dysregulation of rRNA methylation is emerging as a hallmark of cancer, though direct links to GO:0008988 require further study.
From rRNA (adenine-N6-)-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KsgA affect ribosome assembly? | CRISPR knockout of ksgA in E. coli or P. aeruginosa [1, 3] |
| What is the effect of a catalytic point mutation? | CRISPR point mutation (e.g., D13A) in ksgA |
| Can a tagged KsgA rescue phenotypes? | Knock-in of FLAG-tagged ksgA at the endogenous locus |
| Does overexpression of KsgA increase antibiotic resistance? | Overexpression plasmid or CRISPRa in P. aeruginosa |
| What is the role of human DIM1 in mitochondrial translation? | CRISPR knockout in HEK293T; rescue with wild-type or mutant DIM1 |
| How does KsgA contribute to DNA repair? | Knockout in E. coli; oxidative stress and mutation frequency assays |
How to Study the rRNA (adenine-N6-)-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Methyltransferase assay | Enzymatic activity using radioactive SAM | Kinetic analysis, inhibitor screening |
| X-ray crystallography | 3D structure of enzyme-rRNA complex | Mechanistic studies, drug design |
| Ribo-seq | Translation efficiency and ribosome occupancy | Impact of KsgA loss on translation |
| RNA-seq | Transcriptome changes | Global effects of ksgA knockout |
| Mass spectrometry | rRNA modification levels (m6(2)A) | Quantification of methylation |
| CRISPR knockout | Gene function loss | Phenotypic analysis in bacteria and human cells [3, 4] |
| CRISPR point mutation | Specific amino acid substitution | Catalytic mechanism studies |
| CRISPR knock-in | Tagged or mutant gene expression | Localization and interaction studies |
Methyltransferase Activity Assays
In vitro methyltransferase assays using recombinant KsgA and synthetic rRNA fragments or full 30S subunits, with tritiated S-adenosyl-L-methionine, can directly measure GO:0008988 activity. Such assays are used to determine kinetic parameters and to test inhibitors.
Structural Biology
X-ray crystallography and cryo-EM have revealed the structure of KsgA bound to rRNA and S-adenosyl-L-methionine, providing insights into substrate recognition and catalysis. These methods are essential for understanding how mutations affect function.
Ribosome Profiling and RNA Sequencing
Ribo-seq and RNA-seq can assess the impact of KsgA loss on translation efficiency and rRNA modification status. For example, m6(2)A levels can be quantified by mass spectrometry or by reverse transcription signatures.
CRISPR-Cas9 Genome Editing
CRISPR knockout, point mutation, and knock-in models allow functional dissection of ksgA/DIM1 in bacteria, yeast, and human cells [3, 4]. These models are used to study antibiotic resistance, oxidative stress, and mitochondrial function [3, 4].
How CRISPR Can Be Used to Study GO:0008988 rRNA (adenine-N6-)-methyltransferase activity
Knockout
CRISPR knockout of ksgA in Pseudomonas aeruginosa leads to increased sensitivity to oxidative stress and aminoglycosides, demonstrating its role in stress resistance. In human cells, knockout of DIM1 causes mitochondrial translation defects and reduced oxygen consumption.
Point Mutation
Introducing catalytic point mutations (e.g., in the S-adenosyl-L-methionine binding pocket) via CRISPR allows separation of methyltransferase activity from other functions, such as DNA repair [1, 7].
Knock-in
Knock-in of epitope-tagged KsgA at the endogenous locus enables localization and interaction studies without altering expression levels. This approach is useful for studying dynamic N-terminal regions.
Overexpression
CRISPR activation or plasmid-based overexpression of KsgA increases rRNA methylation and can confer antibiotic resistance in bacteria. In eukaryotic cells, overexpression of DIM1 may rescue mitochondrial defects.
How EDITGENE Supports rRNA (adenine-N6-)-methyltransferase activity Research
Researchers studying rRNA (adenine-N6-)-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in ribosome assembly, translation, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for rRNA (adenine-N6-)-methyltransferase activity research.
Frequently Asked Questions About rRNA (adenine-N6-)-methyltransferase activity
What is rRNA (adenine-N6-)-methyltransferase activity?
It is a molecular function (GO:0008988) that catalyzes the methylation of adenine at the N6 position in ribosomal RNA using S-adenosyl-L-methionine, producing N6-methyladenosine and S-adenosyl-L-homocysteine [1, 7].
What genes are involved in rRNA (adenine-N6-)-methyltransferase activity?
The main genes are ksgA in bacteria and DIM1 in eukaryotes and archaea, which encode the enzymes responsible for this modification [5, 7].
Which enzyme carries out rRNA (adenine-N6-)-methyltransferase activity?
KsgA (also called Dim1) is the primary enzyme, a conserved methyltransferase that dimethylates two adjacent adenines in 16S rRNA [5, 7].
What is the role of KsgA in bacteria?
KsgA methylates 16S rRNA, which is essential for ribosome assembly and translation; loss of KsgA increases sensitivity to antibiotics and oxidative stress.
How is rRNA (adenine-N6-)-methyltransferase activity regulated?
It is regulated by growth conditions, the TOR pathway in eukaryotes, and post-translational modifications, though details vary by organism [4, 6].
What diseases are associated with rRNA (adenine-N6-)-methyltransferase activity?
Mutations in human DIM1 cause mitochondrial disease and ribosomopathies; in pathogens, the activity contributes to antibiotic resistance and virulence [3, 4].
How can I study rRNA (adenine-N6-)-methyltransferase activity in the lab?
Common methods include methyltransferase assays, structural biology, Ribo-seq, and CRISPR knockout or point mutation models [2, 7].
What is the reaction catalyzed by GO:0008988?
adenosine in rRNA + S-adenosyl-L-methionine = H+ + N(6)-methyladenosine in rRNA + S-adenosyl-L-homocysteine.
Is KsgA involved in DNA repair?
Yes, Escherichia coli KsgA has a DNA glycosylase/AP lyase activity that prevents mutations, in addition to its rRNA methyltransferase function.
Can CRISPR be used to study rRNA (adenine-N6-)-methyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of ksgA/DIM1 in various organisms [3, 4, 6].
Conclusion
GO:0008988, rRNA (adenine-N6-)-methyltransferase activity, is a fundamental molecular function that ensures proper ribosome assembly and translation across all domains of life. The conserved KsgA/Dim1 enzymes catalyze the dimethylation of 16S rRNA, influencing antibiotic resistance, oxidative stress responses, and mitochondrial function. Dysregulation of this activity is linked to human diseases, including ribosomopathies and mitochondrial disorders. Continued research using CRISPR-based models and advanced sequencing technologies will further illuminate its mechanistic details and therapeutic potential.
References
- 1. Zhang-Akiyama QM et al.. 2009. KsgA, a 16S rRNA adenine methyltransferase, has a novel DNA glycosylase/AP lyase activity to prevent mutations in Escherichia coli.. Nucleic Acids Res 37(7):2116-25 PMID: 19223326
- 2. Gupta K et al.. 2018. Characterization of a Plasmodium falciparum rRNA methyltransferase.. Mol Biochem Parasitol 223:13-18 PMID: 29909066
- 3. Phatinuwat K et al.. 2024. 16S rRNA methyltransferase KsgA contributes to oxidative stress and antibiotic resistance in Pseudomonas aeruginosa.. Sci Rep 14(1):26484 PMID: 39489773
- 4. Richter U et al.. 2010. A mitochondrial rRNA dimethyladenosine methyltransferase in Arabidopsis.. Plant J 61(4):558-69 PMID: 19929881
- 5. Knüppel R et al.. 2021. Insights into synthesis and function of KsgA/Dim1-dependent rRNA modifications in archaea.. Nucleic Acids Res 49(3):1662-1687 PMID: 33434266
- 6. McGaha DA et al.. 2025. Two dynamic N-terminal regions are required for function in ribosomal RNA adenine dimethylase family members.. RNA 31(2):164-180 PMID: 39516040
- 7. Stephan NC et al.. 2021. Structural basis of successive adenosine modifications by the conserved ribosomal methyltransferase KsgA.. Nucleic Acids Res 49(11):6389-6398 PMID: 34086932
